↓ Skip to main content

A Pilot Single-Blinded, Randomized, Controlled Trial Comparing BNT162b2 vs. JNJ-78436735 Vaccine as the Third Dose After Two Doses of BNT162b2 Vaccine in Solid Organ Transplant Recipients

Overview of attention for article published in Transplant International, April 2023
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news
1 news outlet
twitter
2 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
14 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A Pilot Single-Blinded, Randomized, Controlled Trial Comparing BNT162b2 vs. JNJ-78436735 Vaccine as the Third Dose After Two Doses of BNT162b2 Vaccine in Solid Organ Transplant Recipients
Published in
Transplant International, April 2023
DOI 10.3389/ti.2023.10938
Pubmed ID
Authors

Yoichiro Natori, Eric Martin, Adela Mattiazzi, Leopoldo Arosemena, Mariella Ortigosa-Goggins, Sivan Shobana, David Roth, Warren Lee Kupin, George William Burke, Gaetano Ciancio, Mahmoud Morsi, Anita Phancao, Mrudula R. Munagala, Hoda Butrous, Suresh Manickavel, Neeraj Sinha, Katherine Sota, Suresh Pallikkuth, Julia Bini, Jacques Simkins, Shweta Anjan, Rodrigo M. Vianna, Giselle Guerra

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 14 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 3 21%
Student > Doctoral Student 2 14%
Researcher 2 14%
Professor 1 7%
Unknown 6 43%
Readers by discipline Count As %
Unspecified 3 21%
Pharmacology, Toxicology and Pharmaceutical Science 1 7%
Nursing and Health Professions 1 7%
Social Sciences 1 7%
Medicine and Dentistry 1 7%
Other 0 0%
Unknown 7 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 June 2024.
All research outputs
#3,420,072
of 26,194,269 outputs
Outputs from Transplant International
#238
of 1,909 outputs
Outputs of similar age
#64,855
of 429,157 outputs
Outputs of similar age from Transplant International
#7
of 29 outputs
Altmetric has tracked 26,194,269 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,909 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 429,157 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.